Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Minority Interest (2016 - 2021)

Cross Country Healthcare's Minority Interest history spans 8 years, with the latest figure at $534000.0 for Q2 2021.

  • For Q2 2021, Minority Interest rose 25.06% year-over-year to $534000.0; the TTM value through Jun 2021 reached $534000.0, up 25.06%, while the annual FY2020 figure was $534000.0, 38.48% down from the prior year.
  • Minority Interest reached $534000.0 in Q2 2021 per CCRN's latest filing, roughly flat from $534000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $868000.0 in Q4 2019 to a low of $427000.0 in Q2 2020.
  • Average Minority Interest over 5 years is $629777.8, with a median of $637500.0 recorded in 2017.
  • Peak YoY movement for Minority Interest: soared 47.66% in 2017, then tumbled 41.27% in 2020.
  • A 5-year view of Minority Interest shows it stood at $630000.0 in 2017, then grew by 6.35% to $670000.0 in 2018, then rose by 29.55% to $868000.0 in 2019, then crashed by 38.48% to $534000.0 in 2020, then changed by 0.0% to $534000.0 in 2021.
  • Per Business Quant, the three most recent readings for CCRN's Minority Interest are $534000.0 (Q2 2021), $534000.0 (Q1 2021), and $534000.0 (Q4 2020).